Centers

UCSC Chemical Screening Center

EU-OPENSCREEN

TEST

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

info here

Read more

Partnerships

Events

Jobs

Eisiai Partners with Johns Hopkins Brain Science Institute

Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai...

 
View all

UCB To Fund "Mining the Human Microbiome" Project at Harvard

UCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of three years to immunologists at Harvard to study the...

 
View all

GSK and Yale to partner on drug discovery development

GlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies.

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All